Florida, February 22, 2018:

    The Global Cord Stem Cell Banking Market is expected to exceed more than US$ 4.0 Billion by 2022 at a CAGR of 20.0% in the given forecast period.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include China Cord Blood Corporation (China), Cryo-Cell International (U.S.), ViaCord (By Perkin Elmer) (U.S.),StemCyte (U.S.),  Cord Blood Registry (U.S.), Smart Cells (U.K.), Cryo-Save (Netherlands), Cryoviva (India), LifeCell (India), Cordlife (Singapore) and Cordvida (Brazil). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The scope of the report includes a detailed study of global and regional markets Global Cord Stem Cell Banking Market with the reasons given for variations in the growth of the industry in certain regions.

    Browse Full Report: https://www.marketresearchengine.com/cord-stem-cell-banking-market

    The Global Cord Stem Cell Banking Market has been segmented as below:

    By Type Analysis:

    • Cord Blood
    • Cord Blood & Cord Tissue

    By Service Analysis:

    • Collection and Transportation
    • Processing
    • Analysis
    • Storage

    By Application Analysis:

    • Cerebral Palsy
    • Leukemia
    • Thalassemia
    • Anemia
    • Autism
    • Diabetes
    • Others

    By Regional Analysis:

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    This report provides:

    1) An overview of the global market for Cord Stem cell banking and related technologies.
    2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022.
    3) Identifications of new market opportunities and targeted promotional plans for Cord stem cell banking.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    The major driving factors of Global Cord Stem Cell Banking Market are as follows:

    • Increase in number of child births
    • Simple system of extraction
    • Stem Cells in Disease Treatment is potential
    • Support from government authorities for research and development for clinical trials of cord stem cell
    • Umbilical Cord Cell Banks potential is growing
    • Growing knowledge and awareness of cord stem Therapeutics

    The restraining factors of ­Global Cord Stem Cell Banking Market are as follows:

    • High storage cost and maintenance
    • Stem Cell Banking Market is having high competition
    • Lot of changes in legal rules and regulations
    • Cost of cell therapies to treat diseases is high
    • Inferiority in accepting

    Buy Report from here: https://www.marketresearchengine.com/cord-stem-cell-banking-market

    Table of Contents

    1 INTRODUCTION

    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Market Overview

    6 Stem Cell Banking Market, By Bank Type

    6.1 Introduction
    6.2 Cord Blood
    6.3 Cord Tissue

    7 Market By Service

    8 Stem Cell Banking Market, By Application

    9 Stem Cell Banking Market, By Region

    10 Competitive Landscape

    11 Company Profile

    11.1 CBR Systems, Inc.

    11.2 Cordlife

    11.3 Cryo-Cell

    11.4 Cryo-Save AG (A Group of Esperite)

    11.5 Lifecell

    11.6 Stemcyte

    11.7 Viacord

    11.8 Smart Cells International Ltd.

    11.9 Cryoviva India

    11.10 Cordvida

    11.11 China Cord Blood Corporation

    Media Contact

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com

    Source: http://www.financeswire.com/cord-stem-cell-banking-market-to-reach-us-4-billion-by-2022